Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. reduced its stake in shares of Teladoc Health, Inc. (NYSE:TDOC) by 17.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,333 shares of the health services provider’s stock after selling 2,142 shares during the quarter. Principal Financial Group Inc.’s holdings in Teladoc Health were worth $94,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Versant Capital Management Inc raised its stake in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 2,441 shares in the last quarter. Westside Investment Management Inc. raised its position in Teladoc Health by 43.8% in the fourth quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after acquiring an additional 2,800 shares in the last quarter. Private Advisor Group LLC raised its position in Teladoc Health by 26.9% in the third quarter. Private Advisor Group LLC now owns 13,990 shares of the health services provider’s stock worth $128,000 after acquiring an additional 2,962 shares in the last quarter. KBC Group NV raised its position in Teladoc Health by 72.3% in the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock worth $80,000 after acquiring an additional 3,714 shares in the last quarter. Finally, Rhumbline Advisers raised its position in Teladoc Health by 1.8% in the fourth quarter. Rhumbline Advisers now owns 281,420 shares of the health services provider’s stock worth $2,558,000 after acquiring an additional 5,018 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. The Goldman Sachs Group dropped their price target on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. Piper Sandler dropped their price target on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. Oppenheimer dropped their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. Finally, Bank of America boosted their price objective on Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a report on Wednesday, February 12th. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, Teladoc Health presently has an average rating of “Hold” and an average target price of $11.26.

Teladoc Health Trading Down 2.5 %

NYSE:TDOC opened at $9.16 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $15.95. The stock’s 50-day moving average is $10.62 and its two-hundred day moving average is $9.65. The stock has a market cap of $1.59 billion, a PE ratio of -1.59 and a beta of 1.27.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. As a group, equities research analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.